Previous Close | 4.5500 |
Open | 4.5300 |
Bid | 4.5500 x 1000 |
Ask | 4.6200 x 800 |
Day's Range | 4.4000 - 4.6550 |
52 Week Range | 3.1150 - 12.3200 |
Volume | |
Avg. Volume | 25,574 |
Market Cap | 36.832M |
Beta (5Y Monthly) | -0.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.9370 |
Earnings Date | Jun 13, 2022 - Jun 17, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 14.00 |
Subscribe to Yahoo Finance Plus to view Fair Value for NTRB
ORLANDO, FL / ACCESSWIRE / May 27, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of transdermal pharmaceutical products, contract research and development services and the contract manufacture services today announced that an interview with CEO Gareth Sheridan will air on The RedChip Money Report® on Bloomberg TV, May 28, at 7 p.
Niche Companies in Environmental, Space, Technology, Biotechnology, and more in attendanceMIAMI, May 24, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 31st Emerging Growth Conference. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products
Invites Individual and Institutional Investors As Well as Advisors and Analysts, To Attend Its Real-Time, Interactive Presentation at the Emerging Growth ConferenceORLANDO, FL / ACCESSWIRE / May 20, 2022 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), is pleased to announce that it has been invited to present at the Emerging Growth Conference on May 25, 2022.